About
3-methylcrotonyl-CoA carboxylase deficiency (3-MCC) is an inherited condition in which the body is unable to break down certain proteins properly, which can lead to harmful amounts of organic acids and toxins in the body. Early detection and treatment can often help children with 3-MCC lead healthy lives. Each baby with 3-MCC has a different experience. A baby might start showing signs of 3-MCC around 3 to 6 months, 3 years, or even in adulthood. Some babies can have this condition and never show any signs. Symptoms of 3-MCC include poor appetite, sleeping longer or more often, tiredness, behavior changes, irritability, muscle weakness (hypotonia), vomiting, muscle tightness (spasticity), delayed growth, and developmental delays. Many of these signs may occur when a baby eats foods the body cannot break down. Symptoms can be triggered by long periods of time without eating, illnesses, and infections.
Condition Type:
Core Conditions
Frequency:
3-methylcrotonyl-CoA carboxylase deficiency (3-MCC) affects 1 out of every 36,000 to 50,000 babies.
More Information for Parents:
Also known as:
- 3-MCC
- 3-methylcrotonylglycinuria
- BMCC deficiency
- Methylcrotonyl-CoA carboxylase deficiency
Core Conditions
- Propionic Acidemia (PROP)
- Methylmalonic Acidemia (Methylmalonyl-CoA Mutase Deficiency) (MUT)
- Methylmalonic Acidemia (Cobalamin Conditions)
- Isovaleric Acidemia (IVA)
- 3-Methylcrotonyl-CoA Carboxylase Deficiency (3-MCC)
- 3-Hydroxy-3-Methylglutaric Aciduria (HMG)
- Holocarboxylase Synthetase Deficiency (MCD)
- Beta-Ketothiolase Deficiency (BKT)
- Glutaric Acidemia, Type I (GA-1)
- Mucopolysaccharidosis, Type II (MPS II)
- Biotinidase Deficiency (BIOT)
- Critical Congenital Heart Disease (CCHD)
- Cystic Fibrosis (CF)
- Classic Galactosemia (GALT)
- Hearing Loss or Varying Hearing Levels
- Severe Combined Immunodeficiency (SCID)
- X-Linked Adrenoleukodystrophy (X-ALD)
- Pompe
- Spinal Muscular Atrophy (SMA)
- Mucopolysaccharidosis, Type I (MPS I)
Secondary
- Citrullinemia, Type II (CIT II)
- Hypermethioninemia (MET)
- Benign Hyperphenylalaninemia (H-PHE)
- Biopterin Defect in Cofactor Biosynthesis (BIOPT-BS)
- Biopterin Defect in Cofactor Regeneration (BIOPT-REG)
- Ornithine Transcarbamylase Deficiency (OTC)
- Carbamoyl Phosphate Synthetase Deficiency (CPS)
- Tyrosinemia, Type II (TYR II)
- Tyrosinemia, Type III (TYR III)